Cite
HARVARD Citation
Herman, G. et al. (2022). Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial. Lancet infectious diseases. 22 (10), pp. 1444-1454. [Online].